Joycelyn J. X. Lee - Search Results

Year	Number of Results
2015	1
2016	1
2020	2
2021	5
2022	2

1

Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.

Ng HHM, Lee RY, Goh S, Tay ISY, Lim X, Lee B, Chew V, Li H, Tan B, Lim S, Lim JCT, Au B, Loh JJH, Saraf S, Connolly JE, Loh T, Leow WQ, Lee JJX, Toh HC, Malavasi F, Lee SY, Chow P, Newell EW, Choo SP, Tai D, Yeong J, Lim TKH. Ng HHM, et al. J Immunother Cancer. 2020 Aug;8(2):e000987. doi: 10.1136/jitc-2020-000987. J Immunother Cancer. 2020. PMID: 32847986 Free PMC article.

2

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma.

Lee JJX, Chan JJ, Choo SP. Lee JJX, et al. Diseases. 2015 Oct 28;3(4):306-324. doi: 10.3390/diseases3040306. Diseases. 2015. PMID: 28943627 Free PMC article. Review.

3

Resected pancreatic adenocarcinoma: An Asian institution's experience.

Ng KYY, Chow EWX, Jiang B, Lim C, Goh BKP, Lee SY, Teo JY, Tan DMY, Cheow PC, Ooi LLPJ, Chow PKH, Lee JJX, Kam JH, Koh YX, Jeyaraj PR, Tan EK, Choo SP, Chan CY, Chung AYF, Tai D. Ng KYY, et al. Cancer Rep (Hoboken). 2021 Oct;4(5):e1393. doi: 10.1002/cnr2.1393. Epub 2021 May 3. Cancer Rep (Hoboken). 2021. PMID: 33939335 Free PMC article.

4

Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis.

Tan HZ, Lee JJX, Choo CJJ, Loh AHL. Tan HZ, et al. Kidney Res Clin Pract. 2022 Jan;41(1):128-131. doi: 10.23876/j.krcp.21.216. Epub 2021 Dec 29. Kidney Res Clin Pract. 2022. PMID: 34974649 Free PMC article. No abstract available.

5

Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.

Ng KYY, Wong LWJ, Ang AJS, Tan SH, Choo SP, Tai DW, Lee JJX. Ng KYY, et al. Asia Pac J Clin Oncol. 2021 Oct;17(5):e249-e261. doi: 10.1111/ajco.13454. Epub 2020 Sep 1. Asia Pac J Clin Oncol. 2021. PMID: 32875742

6

Myasthenia Gravis and Myocarditis After Administration of Pembrolizumab in a Patient With Metastatic Non-small Cell Lung Cancer and Resected Thymoma.

Kee W, Ng KYY, Lee JJX, Tan DSW. Kee W, et al. Clin Lung Cancer. 2021 Dec 10:S1525-7304(21)00288-6. doi: 10.1016/j.cllc.2021.12.001. Online ahead of print. Clin Lung Cancer. 2021. PMID: 35105525 No abstract available.

7

Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.

Ng KYY, Tan SH, Tan JJE, Tay DSH, Lee AWX, Ang AJS, Wong LWJ, Choo SP, Tai DW, Lee JJX. Ng KYY, et al. Liver Cancer. 2021 Oct 26;11(1):9-21. doi: 10.1159/000518619. eCollection 2022 Jan. Liver Cancer. 2021. PMID: 35222504 Free PMC article.

8

Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma.

Lee JJ, Chan A, Tang T. Lee JJ, et al. Acta Oncol. 2016;55(4):519-20. doi: 10.3109/0284186X.2015.1125017. Epub 2016 Jan 12. Acta Oncol. 2016. PMID: 26754959 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results